Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, Mass.
Division of Allergy, Asthma and Immunology, Scripps Clinic, San Diego, Calif.
J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):208-13.. doi: 10.1016/j.jaip.2013.12.003.
A large percentage of patients with aspirin exacerbated respiratory disease (AERD) report the development of alcohol-induced respiratory reactions, but the true prevalence of respiratory reactions caused by alcoholic beverages in these patients was not known.
We sought to evaluate the incidence and characteristics of alcohol-induced respiratory reactions in patients with AERD.
A questionnaire designed to assess alcohol-induced respiratory symptoms was administered to patients at Brigham and Women's Hospital and Scripps Clinic. At least 50 patients were recruited into each of 4 clinical groups: (1) patients with aspirin challenge-confirmed AERD, (2) patients with aspirin-tolerant asthma (ATA), (3) patients with aspirin tolerance and with chronic rhinosinusitis, and (4) healthy controls. Two-tailed Fisher exact tests with Bonferroni corrections were used to compare the prevalence of respiratory symptoms among AERD and other groups, with P ≤ .017 considered significant.
The prevalence of alcohol-induced upper (rhinorrhea and/or nasal congestion) respiratory reactions in patients with AERD was 75% compared with 33% with aspirin-tolerant asthma, 30% with chronic rhinosinusitis, and 14% with healthy controls (P < .001 for all comparisons). The prevalence of alcohol-induced lower (wheezing and/or dyspnea) respiratory reactions in AERD was 51% compared with 20% in aspirin-tolerant asthma and with 0% in both chronic rhinosinusitis and healthy controls (P < .001 for all comparisons). These reactions were generally not specific to one type of alcohol and often occurred after ingestion of only a few sips of alcohol.
Alcohol ingestion causes respiratory reactions in the majority of patients with AERD, and clinicians should be aware that these alcohol-induced reactions are significantly more common in AERD than in controls who are aspirin tolerant.
很大比例的阿司匹林加重呼吸道疾病(AERD)患者报告发生酒精诱发的呼吸道反应,但这些患者中由酒精饮料引起的呼吸道反应的真实患病率尚不清楚。
我们旨在评估 AERD 患者中酒精诱发的呼吸道反应的发生率和特征。
我们在 Brigham 和妇女医院及 Scripps 诊所向患者发放了一份专门评估酒精诱发的呼吸道症状的问卷。每个临床分组(共 4 个分组)至少招募了 50 名患者:(1)经阿司匹林激发试验证实的 AERD 患者;(2)阿司匹林耐受的哮喘(ATA)患者;(3)阿司匹林耐受且患有慢性鼻-鼻窦炎的患者;(4)健康对照者。使用双侧 Fisher 精确检验和 Bonferroni 校正比较 AERD 组与其他组之间的呼吸道症状发生率,P≤0.017 被认为具有统计学意义。
与阿司匹林耐受的哮喘(33%)、慢性鼻-鼻窦炎(30%)和健康对照者(14%)相比,AERD 患者中酒精诱发的上呼吸道(流涕和/或鼻塞)反应的发生率为 75%(所有比较 P<0.001)。AERD 患者中酒精诱发的下呼吸道(喘息和/或呼吸困难)反应的发生率为 51%,而阿司匹林耐受的哮喘患者中为 20%,慢性鼻-鼻窦炎和健康对照者中为 0%(所有比较 P<0.001)。这些反应通常与某种特定类型的酒精无关,且常发生在仅摄入几小口酒精之后。
酒精摄入可引起大多数 AERD 患者的呼吸道反应,且临床医生应注意,这些酒精诱发的反应在 AERD 患者中比在阿司匹林耐受的对照者中更为常见。